Norges Bank Amgen Inc Transaction History

Norges Bank

$716 Trillion
Q3 2024

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.53 Billion - $1.85 Billion	5,807,622 New	5,807,622 $1.81 Billion
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $1.38 Billion - $1.56 Billion	5,405,570 New	5,405,570 $1.56 Billion
Q3 2023 Nov 13, 2024	BUY	$218.65 - $271.46 $1.17 Billion - $1.45 Billion	5,336,080 New	5,336,080 $1.43 Billion
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.05 Billion - $1.3 Billion	-4,795,544 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$214.27 - $253.37 $55.9 Million - $66.1 Million	-260,982 Reduced 4.49%	5,546,640 $1.23 Billion
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $608 Million - $719 Million	-2,838,666 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$225.79 - $275.2 $1.23 Billion - $1.5 Billion	5,436,784 New	5,436,784 $1.31 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.18 Billion - $1.5 Billion	5,146,885 New	5,146,885 $1.35 Billion
Q3 2022 Nov 13, 2023	BUY	$224.46 - $253.15 $1.08 Billion - $1.21 Billion	4,795,544 New	4,795,544 $1.08 Billion
Q2 2022 Aug 14, 2023	BUY	$230.71 - $256.74 $655 Million - $729 Million	2,838,666 New	2,838,666 $691 Million
Q1 2022 May 12, 2023	SELL	$219.27 - $242.57 $431 Million - $476 Million	-1,963,589 Reduced 38.15%	3,183,296 $770 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $1.11 Billion - $1.23 Billion	-5,062,588 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$198.88 - $227.6 $1.01 Billion - $1.15 Billion	5,062,588 New	5,062,588 $1.14 Billion
Q3 2021 Nov 14, 2022	BUY	$212.27 - $248.7 $1.18 Billion - $1.38 Billion	5,554,829 New	5,554,829 $1.18 Billion
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $1.18 Billion - $1.39 Billion	-5,571,267 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$233.58 - $259.14 $1.3 Billion - $1.44 Billion	5,571,267 New	5,571,267 $1.36 Billion
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $1.37 Billion - $1.52 Billion	-5,873,983 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$221.91 - $258.6 $1.3 Billion - $1.52 Billion	5,873,983 New	5,873,983 $1.46 Billion
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $1.26 Billion - $1.47 Billion	-5,666,224 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$216.38 - $257.67 $1.23 Billion - $1.46 Billion	5,666,224 New	5,666,224 $1.3 Billion
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $1.21 Billion - $1.44 Billion	-5,574,018 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$234.65 - $260.95 $1.31 Billion - $1.45 Billion	5,574,018 New	5,574,018 $1.42 Billion
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $1.32 Billion - $1.47 Billion	-5,622,494 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$197.81 - $242.74 $1.11 Billion - $1.36 Billion	5,622,494 New	5,622,494 $1.33 Billion
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $1.22 Billion - $1.5 Billion	-6,178,853 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$182.24 - $241.7 $1.13 Billion - $1.49 Billion	6,178,853 New	6,178,853 $1.25 Billion
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $1.15 Billion - $1.52 Billion	-6,285,274 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$189.21 - $243.2 $1.19 Billion - $1.53 Billion	6,285,274 New	6,285,274 $1.52 Billion
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $1.22 Billion - $1.57 Billion	-6,465,405 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$174.11 - $208.62 $1.13 Billion - $1.35 Billion	6,465,405 New	6,465,405 $1.25 Billion
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $1.17 Billion - $1.4 Billion	-6,699,869 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$166.7 - $195.41 $1.12 Billion - $1.31 Billion	6,699,869 New	6,699,869 $1.23 Billion
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $1.12 Billion - $1.31 Billion	-6,699,869 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$180.87 - $203.88 $19.5 Million - $22 Million	107,956 Added 1.64%	6,699,869 $1.27 Billion
Q4 2018 Mar 04, 2019	BUY	$178.4 - $208.25 $1.18 Billion - $1.37 Billion	6,591,913 New	6,591,913 $1.28 Billion
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $1.13 Billion - $1.32 Billion	-6,329,397 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$185.29 - $208.89 $1.17 Billion - $1.32 Billion	6,329,397 New	6,329,397 $1.31 Billion
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $1.19 Billion - $1.34 Billion	-6,420,544 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$166.05 - $186.51 $1.07 Billion - $1.2 Billion	6,420,544 New	6,420,544 $1.19 Billion
Q2 2018 Jul 23, 2018	SELL	$166.05 - $186.51 $1.12 Billion - $1.25 Billion	-6,725,473 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$169.43 - $198.0 $1.14 Billion - $1.33 Billion	6,725,473 New	6,725,473 $1.15 Billion
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $1.2 Billion - $1.4 Billion	-7,078,159 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$168.79 - $188.59 $1.19 Billion - $1.33 Billion	7,078,159 New	7,078,159 $1.23 Billion
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.19 Billion - $1.33 Billion	-7,078,159 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$167.29 - $191.0 $1.18 Billion - $1.35 Billion	7,078,159 New	7,078,159 $1.32 Billion
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $1.18 Billion - $1.35 Billion	-7,078,159 Closed	0 $0
Q1 2017 May 11, 2018	BUY	N/A	261,614 Added 3.84%	7,078,159 $1.16 Billion
Q3 2016 Nov 13, 2017	BUY	N/A	6,816,545	6,816,545 $0

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account